These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 27631209)
1. Circulating long noncoding RNA GAS5 is a novel biomarker for the diagnosis of nonsmall cell lung cancer. Liang W; Lv T; Shi X; Liu H; Zhu Q; Zeng J; Yang W; Yin J; Song Y Medicine (Baltimore); 2016 Sep; 95(37):e4608. PubMed ID: 27631209 [TBL] [Abstract][Full Text] [Related]
2. Tumor-derived exosomal lncRNA GAS5 as a biomarker for early-stage non-small-cell lung cancer diagnosis. Li C; Lv Y; Shao C; Chen C; Zhang T; Wei Y; Fan H; Lv T; Liu H; Song Y J Cell Physiol; 2019 Nov; 234(11):20721-20727. PubMed ID: 31032916 [TBL] [Abstract][Full Text] [Related]
3. Circulating long non-coding RNA GAS5 and SOX2OT as potential biomarkers for diagnosis and prognosis of non-small cell lung cancer. Kamel LM; Atef DM; Mackawy AMH; Shalaby SM; Abdelraheim N Biotechnol Appl Biochem; 2019 Jul; 66(4):634-642. PubMed ID: 31077615 [TBL] [Abstract][Full Text] [Related]
4. Identification of circulating long non-coding RNA GAS5 as a potential biomarker for non-small cell lung cancer diagnosisnon-small cell lung cancer, long non-coding RNA, plasma, GAS5, biomarker. Tan Q; Zuo J; Qiu S; Yu Y; Zhou H; Li N; Wang H; Liang C; Yu M; Tu J Int J Oncol; 2017 May; 50(5):1729-1738. PubMed ID: 28339045 [TBL] [Abstract][Full Text] [Related]
5. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer. Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701 [TBL] [Abstract][Full Text] [Related]
6. Circulating Long Non-Coding RNA GAS5: A Non-Invasive Molecular Marker for Prognosis, Response to Treatment and Survival in Non-Small Cell Lung Cancer. Al Mourgi M; El Askary A; Gharib AF; Alzahrani R; Banjer HJ; Elsawy WH; Al Ghamdi AE; Raafat N Cancer Invest; 2021; 39(6-7):505-513. PubMed ID: 33969786 [TBL] [Abstract][Full Text] [Related]
7. Identification of Circulating Long Noncoding RNA Linc00152 as a Novel Biomarker for Diagnosis and Monitoring of Non-Small-Cell Lung Cancer. Li N; Feng XB; Tan Q; Luo P; Jing W; Zhu M; Liang C; Tu J; Ning Y Dis Markers; 2017; 2017():7439698. PubMed ID: 29375177 [TBL] [Abstract][Full Text] [Related]
8. A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer. Peng H; Wang J; Li J; Zhao M; Huang SK; Gu YY; Li Y; Sun XJ; Yang L; Luo Q; Huang CZ Life Sci; 2016 Apr; 151():235-242. PubMed ID: 26946307 [TBL] [Abstract][Full Text] [Related]
9. Expression level of long noncoding RNA H19 in plasma of patients with nonsmall cell lung cancer and its clinical significance. Luo J; Li Q; Pan J; Li L; Fang L; Zhang Y J Cancer Res Ther; 2018; 14(4):860-863. PubMed ID: 29970666 [TBL] [Abstract][Full Text] [Related]
10. Circulating MACC1 as a novel diagnostic and prognostic biomarker for nonsmall cell lung cancer. Wang Z; Cai M; Weng Y; Zhang F; Meng D; Song J; Zhou H; Xie Z J Cancer Res Clin Oncol; 2015 Aug; 141(8):1353-61. PubMed ID: 25544672 [TBL] [Abstract][Full Text] [Related]
11. Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects. Han L; Ma P; Liu SM; Zhou X Tumour Biol; 2016 May; 37(5):6847-54. PubMed ID: 26662314 [TBL] [Abstract][Full Text] [Related]
12. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer. Tantai J; Hu D; Yang Y; Geng J Int J Clin Exp Pathol; 2015; 8(7):7887-95. PubMed ID: 26339353 [TBL] [Abstract][Full Text] [Related]
13. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer. Li W; Li N; Kang X; Shi K Clin Chim Acta; 2017 Dec; 475():152-156. PubMed ID: 29080690 [TBL] [Abstract][Full Text] [Related]
14. Low plasma miR-25 expression is a favorite prognosis factor in non-small cell lung cancer. Zhang YL; Zhang ZL; Zhu XB; Xu L; Lu P; Xu M; Liu WJ; Zhang XY; Yao HM; Ye XW Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5251-5259. PubMed ID: 31298376 [TBL] [Abstract][Full Text] [Related]
15. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer. Shi X; Sun M; Liu H; Yao Y; Kong R; Chen F; Song Y Mol Carcinog; 2015 Jun; 54 Suppl 1():E1-E12. PubMed ID: 24357161 [TBL] [Abstract][Full Text] [Related]
16. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer. Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer. Zhu W; Zhou K; Zha Y; Chen D; He J; Ma H; Liu X; Le H; Zhang Y PLoS One; 2016; 11(4):e0153046. PubMed ID: 27093275 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer. Su K; Zhang T; Wang Y; Hao G World J Surg Oncol; 2016 Aug; 14(1):224. PubMed ID: 27733164 [TBL] [Abstract][Full Text] [Related]
19. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer. Guo W; Zhang Y; Zhang Y; Shi Y; Xi J; Fan H; Xu S Int J Mol Med; 2015 Dec; 36(6):1720-6. PubMed ID: 26497897 [TBL] [Abstract][Full Text] [Related]
20. Increased serum exosomal long non-coding RNA SNHG15 expression predicts poor prognosis in non-small cell lung cancer. Han P; Zhao J; Gao L J Clin Lab Anal; 2021 Nov; 35(11):e23979. PubMed ID: 34551140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]